The Spine Journal
Volume 11, Issue 10 , Pages 966-977, October 2011

The efficacy, safety, effectiveness, and cost-effectiveness of ultrasound and shock wave therapies for low back pain: a systematic review

  • Jesús Seco, MD, PhD

      Affiliations

    • Department of Nursing and Physical Therapy, Institute of Biomedicine (IBIOMED), University of León, Ponferrada, Spain
    • Spanish Back Pain Research Network, Paseo Mallorca 36, 07012 Palma de Mallorca, Spain
    • ,
  • Francisco M. Kovacs, MD, PhD

      Affiliations

    • Spanish Back Pain Research Network, Paseo Mallorca 36, 07012 Palma de Mallorca, Spain
    • Scientific Department, Fundación Kovacs, Palma de Mallorca, Paseo Mallorca 36, 07012 Palma de Mallorca, Spain
    • Corresponding Author InformationCorresponding author. Departamento Científico, Fundación Kovacs, Paseo Mallorca 36, 07012 Palma de Mallorca, Spain. Tel.: (34) 971-720809; fax: (34) 971-720774.
    • ,
  • Gerard Urrutia, MD

      Affiliations

    • Spanish Back Pain Research Network, Paseo Mallorca 36, 07012 Palma de Mallorca, Spain
    • Iberoamerican Cochrane Center-Servei d’Epidemiologia Clínica i Salut Pública, Institut d’Investigació Biomèdica Sant Pau, Hospital de Sant Pau, C/ Sant Antoni Maria Claret, 167, 08025 Barcelona, Spain
    • CIBER Epidemiología y Salud Pública (CIBERESP), Spain

Received 3 September 2010; received in revised form 12 December 2010; accepted 7 February 2011. published online 11 April 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 FDA device/drug status: Not applicable.

 Author disclosures: JS: Nothing to disclose. FMK: Nothing to disclose. GU: Nothing to disclose.

 Gerard Urrutia is a PhD candidate at the Public Health and Research Methodology Programme, Universitat Autonoma de Barcelona (UAB).

PII: S1529-9430(11)00126-4

doi:10.1016/j.spinee.2011.02.002

The Spine Journal
Volume 11, Issue 10 , Pages 966-977, October 2011

Article Tools